Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-30

FDA Approved: FLUPHENAZINE DECANOATE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved a generic fluphenazine decanoate long-acting injectable from Sagent Pharmaceuticals under an Original Application, enabling a generic option fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine decanoate (Fluphenazine decanoate)

Snippet

ORIG AP for FLUPHENAZINE DECANOATE (FLUPHENAZINE DECANOATE)